Cargando…
Proceedings: Protection against the cytotoxic aziridine CB1954 by an arylimidazole with anti-inflammatory activity.
Autores principales: | Hickman, J. A., Melzack, D. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024879/ https://www.ncbi.nlm.nih.gov/pubmed/1212363 |
Ejemplares similares
-
Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954
por: Talib, Wamidh H., et al.
Publicado: (2013) -
Bis(arylimidazole) Iridium Picolinate Emitters and
Preferential Dipole Orientation in Films
por: Huckaba, Aron J., et al.
Publicado: (2018) -
Influence of Steric Effect on the Pseudo-Multicomponent Synthesis of N-Aroylmethyl-4-Arylimidazoles
por: Elejalde-Cadena, Nerith Rocio, et al.
Publicado: (2022) -
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
por: Vass, S O, et al.
Publicado: (2009) -
Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro
por: Teng, Geling, et al.
Publicado: (2016)